Literature DB >> 10576310

To what extent does symptomatic improvement result in better outcome in psychotic illness? UK700 Group.

J van Os1, C Gilvarry, R Bale, E van Horn, T Tattan, I White, R Murray.   

Abstract

BACKGROUND: The effectiveness of therapeutic interventions in psychosis is increasingly reported in terms of reductions in different symptom dimensions. It remains unclear, however, to what degree such symptomatic changes are accompanied by improvement in other measures such as service use, quality of life, and needs for care.
METHODS: A sample of 708 patients with chronic psychotic illness was assessed on three occasions over 2 years (baseline, year 1 and year 2). A multilevel analysis was conducted to examine to what degree reduction in psychopathological scores derived from factor analysis of the Comprehensive Psychopathological Rating Scale (CPRS), was associated with improvement in service use, disability, subjective outcomes and measures of self-harm.
RESULTS: Reduction in positive, negative, depressive and manic symptoms over the study period were all independently associated with lessening of social disability. Reduction in negative symptoms, and to a lesser extent in positive and manic symptoms, was associated with less time in hospital and more time living independently, whereas changes in positive and manic symptoms resulted in fewer admissions. Subjective outcomes such as improvement in quality of life, perceived needs for care and dissatisfaction with services showed the strongest associations with reduction in depressive symptoms. Reduction in positive symptoms was associated with decreased likelihood of parasuicide. Results did not differ according to diagnostic category.
CONCLUSION: The findings suggest that changes in distinct psychopathological dimensions independently and differentially influence outcome. Therapeutic interventions aimed at reducing symptoms of more than one dimension are likely to have more widespread effects.

Entities:  

Mesh:

Year:  1999        PMID: 10576310     DOI: 10.1017/s0033291799001014

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  5 in total

Review 1.  [Schizophrenia and depression].

Authors:  K Maurer; G Trendler; M Schmidt; W An der Heiden; R Könnecke; H Häfner
Journal:  Nervenarzt       Date:  2006-07       Impact factor: 1.214

2.  The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia.

Authors:  Daniela Schaub; Martin Brüne; Elisabeth Jaspen; Frank-Gerald Pajonk; Hans-Werner Bierhoff; Georg Juckel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-22       Impact factor: 5.270

3.  Is processing speed predictive of functional outcome in psychosis?

Authors:  Nienke Jabben; Jim van Os; Tom Burns; Francis Creed; Theresa Tattan; John Green; Peter Tyrer; Robin Murray; Lydia Krabbendam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-02-29       Impact factor: 4.328

4.  The use of a Cumulative Needs for Care Monitor for individual treatment v. care as usual for patients diagnosed with severe mental illness, a cost-effectiveness analysis from the health care perspective.

Authors:  M Drukker; M Joore; J van Os; S Sytema; G Driessen; M Bak; Ph Delespaul
Journal:  Epidemiol Psychiatr Sci       Date:  2012-05-22       Impact factor: 6.892

5.  Prognostic Value of Affective Symptoms in First-Admission Psychotic Patients.

Authors:  Marta Arrasate; Itxaso González-Ortega; Adriana García-Alocén; Susana Alberich; Iñaki Zorrilla; Ana González-Pinto
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.